MannKind Corp (MNKD)

0.68
0.00 0.29
NASDAQ : Health Care
Prev Close 0.68
Open 0.67
Day Low/High 0.66 / 0.67
52 Wk Low/High 0.64 / 5.37
Volume 655.20K
Avg Volume 5.38M
Exchange NASDAQ
Shares Outstanding 478.38M
Market Cap 330.08M
EPS -0.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

2016 Was a Terrible Year for Biotech but the Tweets Were on Point

2016 Was a Terrible Year for Biotech but the Tweets Were on Point

2016 tweets by TheStreet's Adam Feuerstein kept us informed and entertained. From an unexpected twist on New Year's day with MannKind to J.P. Morgan's Healthcare conference to Bristol-Myers Squibb's oops!

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

2016 Was a Terrible Year for Biotech but the Tweets Were on Point

2016 Was a Terrible Year for Biotech but the Tweets Were on Point

A look back at the year's worth of Adam Feuerstein's biotech tweets.

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.

In Case You Missed It Thursday: Everyone (but Pfizer) May Still Need Some Advil

In Case You Missed It Thursday: Everyone (but Pfizer) May Still Need Some Advil

Donald Trump's victory may be a win for Wall Street traders; Colgate-Palmolive remains on slippery slope; and more from TheStreet and its various properties.

MannKind Is Still Too Heavy to Avoid the Afrezza Crash Landing

MannKind Is Still Too Heavy to Avoid the Afrezza Crash Landing

MannKind bulls -- the rainbow-hued unicorns of the investment world -- believe the company's marketing efforts will succeed. They're wrong.

MannKind Corporation Reports 2016 Third Quarter Financial Results

MannKind Corporation Reports 2016 Third Quarter Financial Results

- Conference Call to Begin Today at 5:00 PM ET -

Tax-Loss Selling Offers Stock-Picking Opportunities

Our screen reveals 17 names that could become oversold and disconnected from their fundamentals as a result of this phenomenon.

First Week of December 16th Options Trading For MannKind (MNKD)

First Week of December 16th Options Trading For MannKind (MNKD)

Investors in MannKind Corp saw new options begin trading this week, for the December 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNKD options chain for the new December 16th contracts and identified the following put contract of particular interest.

Will Insiders Be Tempted To Buy More MNKD At The New 52-Week Low?

Will Insiders Be Tempted To Buy More MNKD At The New 52-Week Low?

In trading on Friday, shares of MannKind Corp touched a new 52-week low of $0.61/share. That's a $3.18 share price drop, or -83.91% decline from the 52-week high of $3.79 set back on 10/28/2015.

Notable Wednesday Option Activity: MNKD, IDI, BYD

Notable Wednesday Option Activity: MNKD, IDI, BYD

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in MannKind Corp , where a total of 77,659 contracts have traded so far, representing approximately 7.8 million underlying shares. That amounts to about 183% of MNKD's average daily trading volume over the past month of 4.2 million shares.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look ready to break out and trade higher from current levels.

Big Pharma's Punishment in Court of Public Opinion

Big Pharma's Punishment in Court of Public Opinion

Immediate public backlash on social media could end up being a more costly verdict for drugmakers' pricing powers.

MNKD: Insiders vs. Shorts

MNKD: Insiders vs. Shorts

The most recent short interest data was recently released for the 07/29/2016 settlement date, and MannKind Corp is one of the most shorted stocks of the Russell 3000, based on 46.40 "days to cover" versus the median component at 6.42. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

MannKind Corporation Reports 2016 Second Quarter Financial Results

MannKind Corporation Reports 2016 Second Quarter Financial Results

Conference Call to Begin Today at 5:00 PM ET

What to Expect from MannKind's (MNKD) Q2 Earnings Report

What to Expect from MannKind's (MNKD) Q2 Earnings Report

MannKind (MNKD) is set to report 2016 second quarter results after Monday's market close.

Mannkind Assumes Responsibility For Distribution Of Afrezza® And Launches Patient Reimbursement And Adherence Support Programs

Mannkind Assumes Responsibility For Distribution Of Afrezza® And Launches Patient Reimbursement And Adherence Support Programs

Frank Pompilio, PharmD, joins as Vice President, North America Medical Affairs

Commit To Purchase MannKind Corp At $0.50, Earn 24% Using Options

Commit To Purchase MannKind Corp At $0.50, Earn 24% Using Options

Investors considering a purchase of MannKind Corp shares, but tentative about paying the going market price of $0.9858/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2018 put at the $0.50 strike, which has a bid at the time of this writing of 12 cents.